Momenta Pharmaceuticals Leadership

Craig A. Wheeler has served as our President and a director since August 2006 and was appointed our Chief Executive Officer effective September 2006. Prior to joining Momenta, Mr. Wheeler served as President of Chiron Biopharmaceuticals, a division of Chiron Corporation, a biotechnology company, from August 2001 until June 2006. Mr. Wheeler has been a member of the board of directors of Avanir Pharmaceuticals, Inc. since September 2005 and has served as chairman of the board since May 2007. Mr. Wheeler received B.S. and M.S. degrees in chemical engineering from Cornell University and an M.B.A. degree from the Wharton School of the University of Pennsylvania.

Jo-Ann Beltramello is a Senior VP:Human Resources at MOMENTA PHARMACEUTICALS INC and Chief Human Resources & Infrastructure Officer at MOMENTA PHARMACEUTICALS INC. She has worked as Chief Human Resources Officer at MultiPlan Inc. Jo-ann works or has worked at Private Healthcare Systems, Inc..

Santiago Arroyo, M.D., Ph.D. is a Chief Medical Officer at MOMENTA PHARMACEUTICALS INC and is based in Cambridge, Massachusetts. He has worked as Vice President, Chief Medical Officer, Neusentis (Pain and Regenerative Medicine Research Unit) at Pfizer Worldwide R&D; Senior Vice President, Head of Clinical Research and Chief Medical Officer at Pfizer Worldwide R&D; and Chief Medical Officer at Boston Pharmaceuticals.

Tony Manning PhD is a Chairman at Instiute for Biomedical Entrepreneurship, Chief Scientific Officer at MOMENTA PHARMACEUTICALS INC, and Board of Directors at PALATIN TECHNOLOGIES INC and is based in Cambridge, Massachusetts. He has worked as Vice President and Global Head, Inflammation, Autoimmunity & Transplantation Research at Roche; Senior Research Scientist at PHARMACIA & UPJOHN COMPANY; and Vice President, Inflammation & Autoimmune Diseases Research at BIOGEN INC.. Tony studied at UNIVERSITY OF OTAGO between 1986 and 1990.

Craig A. Wheeler has served as our President and a director since August 2006 and was appointed our Chief Executive Officer effective September 2006. Prior to joining Momenta, Mr. Wheeler served as President of Chiron Biopharmaceuticals, a division of Chiron Corporation, a biotechnology company, from August 2001 until June 2006. Mr. Wheeler has been a member of the board of directors of Avanir Pharmaceuticals, Inc. since September 2005 and has served as chairman of the board since May 2007. Mr. Wheeler received B.S. and M.S. degrees in chemical engineering from Cornell University and an M.B.A. degree from the Wharton School of the University of Pennsylvania.

Accomplished biotech executive with several key roles in a public biotech company, including chief financial officer and chief business officer. Experience leading corporate strategy and business development activities, using transactions to shape and grow a complex business. Led equity financing / capital raising activities important to the long-term strategic plan. Drove extensive interactions with investors and sell-side analysts to articulate the company’s vision and opportunities, as investor relations lead. Also managed commercial activities, as Momenta planned for success of its clinical programs.